Selected article for: "good sensitivity and specificity good sensitivity"
Author: Steffens, Ines
Title: A hundred days into the coronavirus disease (COVID-19) pandemic
  • Document date: 2020_4_9
    • ID: 16myb2n5_7
    Snippet: The focus of ongoing research includes determining the duration of virus shedding and infectiousness. Development of serological tests with good sensitivity and specificity for wide-scale use is necessary to assess population immunity. Serological studies have been started in several European countries to define population immunity and studies on the duration of immunity will need to be conducted in the future. Clinical trials are being conducted.....
    Document: The focus of ongoing research includes determining the duration of virus shedding and infectiousness. Development of serological tests with good sensitivity and specificity for wide-scale use is necessary to assess population immunity. Serological studies have been started in several European countries to define population immunity and studies on the duration of immunity will need to be conducted in the future. Clinical trials are being conducted worldwide to investigate treatment options with a variety of antiviral and other drugs. The World Health Organization (WHO) and European Union-funded projects are coordinating multi-centre adaptive trials to assess the effectiveness of remdesivir, hydroxychloroquine and a combination of lopinavir and ritonavir with or without interferon-beta-1a [16, 17] . A number of vaccine trials are ongoing worldwide with earliest results expected within the coming 18 months.

    Search related documents:
    Co phrase search for related documents
    • adaptive trial and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive trial and multi centre adaptive trial: 1, 2
    • antiviral drug and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and european country: 1
    • antiviral drug and ongoing research: 1, 2, 3, 4, 5
    • clinical trial and early result: 1, 2, 3, 4
    • clinical trial and future conduct: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical trial and good sensitivity: 1, 2
    • clinical trial and immunity duration: 1, 2, 3
    • clinical trial and multi centre adaptive trial: 1
    • clinical trial and ongoing research: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • early result and good sensitivity: 1
    • early result and ongoing research: 1